Gavin Bushey
2 posts
@_PurpleBiotech as a long-term investor, I'm frustrated by the declining stock price and no updates on clinical data for drugs NT219 and CM24. Transparency is key to maintain investor confidence. Please provide insight into the progress. #InvestorConcerns
English